Epigenetic Modifications in Essential Hypertension

Ingrid Wise; Fadi Charchar

doi:10.3390/ijms17040451

journal article Open Access Mar 25, 2016

Epigenetic Modifications in Essential Hypertension

Ingrid Wise Fadi Charchar

International Journal of Molecular Sciences Vol. 17 No. 4 pp. 451 · MDPI AG

View at Publisher Save 10.3390/ijms17040451

Abstract

Essential hypertension (EH) is a complex, polygenic condition with no single causative agent. Despite advances in our understanding of the pathophysiology of EH, hypertension remains one of the world’s leading public health problems. Furthermore, there is increasing evidence that epigenetic modifications are as important as genetic predisposition in the development of EH. Indeed, a complex and interactive genetic and environmental system exists to determine an individual’s risk of EH. Epigenetics refers to all heritable changes to the regulation of gene expression as well as chromatin remodelling, without involvement of nucleotide sequence changes. Epigenetic modification is recognized as an essential process in biology, but is now being investigated for its role in the development of specific pathologic conditions, including EH. Epigenetic research will provide insights into the pathogenesis of blood pressure regulation that cannot be explained by classic Mendelian inheritance. This review concentrates on epigenetic modifications to DNA structure, including the influence of non-coding RNAs on hypertension development.

Topics

No keywords indexed for this article. Browse by subject →

References

68

[1]

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

Stephen S Lim, Theo Vos, Abraham D Flaxman et al.

The Lancet 2013 10.1016/s0140-6736(12)61766-8

[2]

Poulter "Hypertension" Lancet (2015) 10.1016/s0140-6736(14)61468-9

[3]

Kunes "The interaction of genetic and environmental factors in the etiology of hypertension" Physiol. Res. (2009) 10.33549/physiolres.931913

[4]

Epigenetic Modifications: Basic Mechanisms and Role in Cardiovascular Disease (2013 Grover Conference Series)

Joseph Loscalzo, Diane E. Handy

Pulmonary Circulation 2014 10.1086/675979

[5]

Lorenzen "Epigenetic modifications in cardiovascular disease" Basic Res. Cardiol. (2012) 10.1007/s00395-012-0245-9

[6]

Khalil "The emerging role of epigenetics in cardiovascular disease" Ther. Adv. Chronic Dis. (2014) 10.1177/2040622314529325

[7]

Wang "Hypertensive epigenetics: From DNA methylation to microRNAs" J. Hum. Hypertens. (2015) 10.1038/jhh.2014.132

[8]

Thum "MicroRNAs in hypertension: Mechanisms and therapeutic targets" Curr. Hypertens. Rep. (2012) 10.1007/s11906-011-0235-6

[9]

Millis "Epigenetics and hypertension" Curr. Hypertens. Rep. (2011) 10.1007/s11906-010-0173-8

[10]

Raftopoulos "Epigenetics, the missing link in hypertension" Life Sci. (2015) 10.1016/j.lfs.2014.08.003

[11]

Camacho "The role of environment and epigenetics in hypertension" Expert Rev. Cardiovasc. Ther. (2013) 10.1586/14779072.2013.846217

[12]

Rakyan, V.K., Hildmann, T., Novik, K.L., Lewin, J., Tost, J., Cox, A.V., Andrews, T.D., Howe, K.L., Otto, T., and Olek, A. (2004). DNA methylation profiling of the human major histocompatibility complex: A pilot study for the human epigenome project. PLoS Biol., 2. 10.1371/journal.pbio.0020405

[13]

Abbott "Project set to map marks on genome" Nature (2010) 10.1038/463596b

[14]

Kelsey, G., and Feil, R. (2013). New insights into establishment and maintenance of DNA methylation imprints in mammals. Philos. Trans. R. Soc. Biol. Sci., 368. 10.1098/rstb.2011.0336

[15]

Kunes "Critical developmental periods in the pathogenesis of hypertension" Physiol. Res. (2012) 10.33549/physiolres.932364

[16]

Wilson "Epigenetic regulation of gene expression in the inflammatory response and relevance to common diseases" J. Periodontol. (2008) 10.1902/jop.2008.080172

[17]

Miranda "DNA methylation: The nuts and bolts of repression" J. Cell. Physiol. (2007) 10.1002/jcp.21224

[18]

Fouse "Genome-scale DNA methylation analysis" Epigenomics (2010) 10.2217/epi.09.35

[19]

Smolarek "Global DNA methylation changes in blood of patients with essential hypertension" Med. Sci. Monit. Basic Res. (2010)

[20]

Kato "Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation" Nat. Genet. (2015) 10.1038/ng.3405

[21]

Friso "Epigenetic control of 11 β-hydroxysteroid dehydrogenase 2 gene promoter is related to human hypertension" Atherosclerosis (2008) 10.1016/j.atherosclerosis.2007.11.029

[22]

Goyal "Brain renin-angiotensin system: Fetal epigenetic programming by maternal protein restriction during pregnancy" Reprod. Sci. (2010) 10.1177/1933719109351935

[23]

Wang, X., Falkner, B., Zhu, H., Shi, H., Su, S., Xu, X., Sharma, A.K., Dong, Y., Treiber, F., and Gutin, B. (2013). A genome-wide methylation study on essential hypertension in young african american males. PLoS ONE, 8. 10.1371/journal.pone.0053938

[24]

Pei "Differential expression and DNA methylation of angiotensin type 1A receptors in vascular tissues during genetic hypertension development" Mol. Cell. Biochem. (2015) 10.1007/s11010-014-2295-9

[25]

Lienhard "Epigenetic regulation of somatic angiotensin-converting enzyme by DNA methylation and histone acetylation" Epigenetics (2011) 10.4161/epi.6.4.14961

[26]

Lee "Promoter hypomethylation upregulates Na+-K+-2Cl− cotransporter 1 in spontaneously hypertensive rats" Biochem. Biophys. Res. Commun. (2010) 10.1016/j.bbrc.2010.04.074

[27]

Ferrari "In vivo 11β-HSD-2 activity variability, salt-sensitivity, and effect of licorice" Hypertension (2001) 10.1161/hy1101.096112

[28]

Udali "Cardiovascular epigenetics: From DNA methylation to microRNAs" Mol. Asp. Med. (2013) 10.1016/j.mam.2012.08.001

[29]

Bogdarina "Epigenetic modification of the renin-angiotensin system in the fetal programming of hypertension" Circ. Res. (2007) 10.1161/01.res.0000258855.60637.58

[30]

Zhang "E112D polymorphism in the prolylcarboxypeptidase gene is associated with blood pressure response to benazepril in chinese hypertensive patients" Chin. Med. J. (2009)

[31]

Esler "Human sympathetic nerve biology: Parallel influences of stress and epigenetics in essential hypertension and panic disorder" Ann. N. Y. Acad. Sci. (2008) 10.1196/annals.1410.064

[32]

Jenuwein "Translating the histone code" Science (2001) 10.1126/science.1063127

[33]

Han "Resveratrol affects histone 3 lysine 27 methylation of vessels and blood biomarkers in DOCA salt-induced hypertension" Mol. Biol. Rep. (2015) 10.1007/s11033-014-3737-x

[34]

Fish "The expression of endothelial nitric-oxide synthase is controlled by a cell-specific histone code" J. Biol. Chem. (2005) 10.1074/jbc.m502115200

[35]

Lee "Tissue-specific upregulation of angiotensin-converting enzyme 1 in spontaneously hypertensive rats through histone code modifications" Hypertension (2012) 10.1161/hypertensionaha.111.182428

[36]

Cho "Upregulation of the Na+-K+-2Cl− cotransporter 1 via histone modification in the aortas of angiotensin II-induced hypertensive rats" Hypertens. Res. (2012) 10.1038/hr.2012.37

[37]

Duarte "Effects of genetic variation in H3K79 methylation regulatory genes on clinical blood pressure and blood pressure response to hydrochlorothiazide" J. Transl. Med. (2012) 10.1186/1479-5876-10-56

[38]

Mu "Epigenetic modulation of the renal β-adrenergic-WNK4 pathway in salt-sensitive hypertension" Nat. Med. (2011) 10.1038/nm.2337

[39]

Bhatt "Resveratrol prevents endothelial nitric oxide synthase uncoupling and attenuates development of hypertension in spontaneously hypertensive rats" Eur. J. Pharmacol. (2011) 10.1016/j.ejphar.2011.05.026

[40]

"Arteriolar remodeling in essential hypertension: Are connective tissue growth factor and transforming growth factor involved?" Kidney Int. (2006) 10.1038/sj.ki.5000222

[41]

Katholi "Importance of renal sympathetic tone in the development of DOCA-salt hypertension in the rat" Hypertension (1980) 10.1161/01.hyp.2.3.266

[42]

DiBona "Physiology in perspective: The wisdom of the body. Neural control of the kidney" Am. J. Physiol. Regul. Integr. Comp. Physiol. (2005) 10.1152/ajpregu.00258.2005

[43]

Guild "Regional responsiveness of renal perfusion to activation of the renal nerves" Am. J. Physiol. Regul. Integr. Comp. Physiol. (2002) 10.1152/ajpregu.00151.2002

[44]

Kahle "Molecular physiology of the WNK kinases" Annu. Rev. Physiol. (2008) 10.1146/annurev.physiol.70.113006.100651

[45]

Chiga "Dietary salt regulates the phosphorylation of OSR1/SPAK kinases and the sodium chloride cotransporter through aldosterone" Kidney Int. (2008) 10.1038/ki.2008.451

[46]

Marshall "Dietary electrolyte-driven responses in the renal WNK kinase pathway in vivo" J. Am. Soc. Nephrol. (2006) 10.1681/asn.2005111197

[47]

Lee "Negative regulation of histone deacetylase 8 activity by cyclic AMP-dependent protein kinase A" Mol. Cell. Biol. (2004) 10.1128/mcb.24.2.765-773.2004

[48]

Mulholland "Chromatin-dependent regulation of the MMTV promoter by cAMP signaling is mediated through distinct pathways" Exp. Cell Res. (2003) 10.1016/s0014-4827(03)00153-8

[49]

Tronche "Conditional transgenic mice for studying the role of the glucocorticoid receptor in the renal collecting duct" Endocrinology (2009) 10.1210/en.2008-1531

[50]

Costa "Non-coding RNAs, epigenetics and complexity" Gene (2008) 10.1016/j.gene.2007.12.008

Showing 50 of 68 references

Cited By

90

Epigenetic Signatures in Arterial Hypertension: Focus on the Microvasculature

Alessandro Mengozzi, Sarah Costantino · 2023

International Journal of Molecular...

Epigenetic modification: a regulatory mechanism in essential hypertension

Mohammed Arif, Sakthivel Sadayappan · 2019

Hypertension Research

Epigenetic Mechanisms and Hypertension

Mingyu Liang · 2018

Hypertension

Is There a Role for Genomics in the Management of Hypertension?

Jacopo Burrello, Silvia Monticone · 2017

International Journal of Molecular...

Metrics

90

Citations

68

References

Details

Published: Mar 25, 2016
Vol/Issue: 17(4)
Pages: 451
License: View

Authors

I

Ingrid Wise

Faculty of Science & Technology, Federation University Australia, University Drive, Mount Helen, VIC 3350, Australia

F

Fadi Charchar

Faculty of Science & Technology, Federation University Australia, University Drive, Mount Helen, VIC 3350, Australia

Cite This Article

Ingrid Wise, Fadi Charchar (2016). Epigenetic Modifications in Essential Hypertension. International Journal of Molecular Sciences, 17(4), 451. https://doi.org/10.3390/ijms17040451

Epigenetic Modifications in Essential Hypertension

You May Also Like